Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3212]

Medical Education Workshop on Molecular Targeted Therapy of Cancer

Medical Education Workshop on Molecular Targeted Therapy of Cancer

Researchers study use of dasatinib for patients with high-risk MDS

Researchers study use of dasatinib for patients with high-risk MDS

Genetically modified immunotherapy shows promise in B-cell acute leukaemia

Genetically modified immunotherapy shows promise in B-cell acute leukaemia

Cancer Research Technology and the Institute of Cancer Research enter collaboration with Janssen to discover multiple myeloma drug

Cancer Research Technology and the Institute of Cancer Research enter collaboration with Janssen to discover...

Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect

Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect

NICE consults on preliminary recommendations for a new treatment for enlarged spleen in adults with myelofibrosis

NICE consults on preliminary recommendations for a new treatment for enlarged spleen in adults with myelofibrosis

Study shows bendamustine-rituximab doubles progression-free survival in patients with iNHL and MCL compared with CHOP-R

Study shows bendamustine-rituximab doubles progression-free survival in patients with iNHL and MCL compared with...

Study shows alcohol consumption is a leading preventable cause of cancer death in the US

Study shows alcohol consumption is a leading preventable cause of cancer death in the US

Risk of leukaemia after cancer chemotherapy persists

Risk of leukaemia after cancer chemotherapy persists

$FDA gives breakthrough therapy designation for ibrutinib for relapsed or refractory mantle cell lymphoma and Waldenstrom's macroglobulinemia$

FDA gives breakthrough therapy designation for ibrutinib for relapsed or refractory mantle cell lymphoma and...

More from ecancer